Vivos Therapeutics, Inc. Company profile
About Vivos Therapeutics Inc
Vivos Therapeutics, Inc. is a medical technology company. The Company is focused on the development and commercialization to dental practices of a patented oral appliance technology and related protocols called the Vivos System. The Company's Vivos System is a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for people with sleep disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The Company’s business model is focused on dentists, and the Company’s program to train dentists and offer them other value-added services in connection with their ordering and use of the Vivos System for patients is called the Vivos Integrated Practice (VIP) program. Its primary product used in the Vivos System is the mRNA appliance, a specifically designed, custom oral appliance that is worn primarily in the evening hours and overnight and is available for adults.
Financial summary
BRIEF: For the nine months ended 30 September 2021, Vivos Therapeutics Inc revenues increased 28% to $12.5M. Net loss increased from $5.8M to $12.9M. Revenues reflect Appliance sales to integrated providers segment increase of 40% to $4.5M, VIP segment increase of 11% to $6.4M. Higher net loss reflects General and administrative increase of 54% to $17.7M (expense), Sales and marketing increase from $1.5M to $4.2M (expense).
Latest shares articles
![](https://img.capital.com/imgs/articles/384x2000x0/1350x880_-HP-_Newsquawk-light_1.png)
![Lloyds share price forecast: An attractive dividend stock?](https://img.capital.com/imgs/articles/384x2000x0/Hero-image-bank_1.png)
![Exterior of Infosys headquarters](https://img.capital.com/imgs/articles/384x2000x0/shutterstock_2035197281_0_0.jpg)
![Tesla logo atop of a Tesla Dealership illuminated at night.](https://img.capital.com/imgs/articles/384x2000x0/shutterstock_1494516293_0.jpg)